Mallinckrodt
Harry Boparai is an experienced optometric physician currently serving at Airis Eye since March 2024. In addition to this role, Boparai is a professional speaker for both Bausch + Lomb and Mallinckrodt Pharmaceuticals since February 2024 and February 2022 respectively, and has been a consultant for Alcon Laboratories, Inc. since April 2013. Boparai has also functioned as a core speaker for Allergan since September 2013 and was an optometrist at Overlake EyeCare, P.S. from March 2014 to March 2024. Previous roles include membership on the Vision Advisory Board for WellPoint and service in the NYC Medical Reserve Corps. Boparai holds a Doctor of Optometry degree from the State University of New York College of Optometry and a Bachelor's degree in Chemistry from Wayne State University.
This person is not in any teams
This person is not in any offices
Mallinckrodt
11 followers
Mallinckrodt develops, manufactures, markets and distributes innovative treatments for underserved patient populations within neurology, rheumatology, nephrology, pulmonology, and ophthalmology.